Showing results (491-500 of 7,003) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Serum lipid profile discriminates patients with early lung cancer from healthy controlsMałgorzata Ros-Mazurczyk, Karol Jelonek, Michał Marczyk, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
MHC class II expression in lung cancerYayi He, Leslie Rozeboom, Christopher J Rivard, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohortKenji Sawa, Yasuhiro Koh, Tomoya Kawaguchi, et al.Lung Cancer (Amsterdam, Netherlands)|August 1, 1997
Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancerC F Quirt, W J Mackillop, A D Ginsburg, et al.Lung Cancer (Amsterdam, Netherlands)|October 8, 1997
Risk factors for lung cancer among women in PolandJ Rachtan, A SokolowskiLung Cancer (Amsterdam, Netherlands)|October 8, 1997
Tumour cell kinetics as prognostic factor in surgically-treated-non-small cell lung cancerA Gasińska, L Kolodziejski, B BiesagaLung Cancer (Amsterdam, Netherlands)|October 8, 1997
Radiation therapy for stage III non-small cell lung cancer invading chest wallY Saito, K Hayakawa, Y Nakayama, et al.Lung Cancer (Amsterdam, Netherlands)|October 8, 1997
Phase I/II trial of low dose cyclosporin A with EP for advanced non-small cell lung cancerH J Ross, J Cho, K Osann, et al.Lung Cancer (Amsterdam, Netherlands)|January 28, 1998
The relation between various histological types of lung cancer and the number of years since cessation of smokingH Pohlabeln, K H Jöckel, K M MüllerLung Cancer (Amsterdam, Netherlands)|January 28, 1998
Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas?A G Nicholson, A N Graham, F Pezzella, et al.Pageof 701